Clicky

Bio-Path Holdings Inc(BPTH) News

Date Title
Oct 9 Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
Oct 8 ACHR, BPTH, PLUG, REGRF:
Oct 8 Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
Oct 8 Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
Sep 4 Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24
Aug 15 Bio-Path: Q2 Earnings Snapshot
Aug 15 Bio-Path Holdings Reports Second Quarter 2024 Financial Results
Jun 14 Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
May 15 Bio-Path Holdings Reports First Quarter 2024 Financial Results
May 8 Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
Apr 19 Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Apr 19 Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Apr 18 Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Apr 18 Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Apr 15 Bio-Path Holdings Expands Global Patent Portfolio
Apr 2 Bio-Path Holdings Provides 2024 Clinical and Operational Update
Mar 27 Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23
Mar 10 Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
Mar 9 Q4 2023 Bio Path Holdings Inc Earnings Call
Mar 8 Bio-Path Holdings Reports Full Year 2023 Financial Results